Enveric Biosciences, Inc. financial data

Symbol
ENVB on Nasdaq
Industry
Pharmaceutical Preparations
Location
4851 Tamiami Trail N, Suite 200, Naples, FL
Fiscal year end
December 31
Former names
AMERI Holdings, Inc. (to 12/30/2020), SPATIALIZER AUDIO LABORATORIES INC (to 5/27/2015)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 390 % +86.8%
Return On Assets -168 % +11.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.47M shares -66.1%
Common Stock, Shares, Outstanding 678K shares +271%
Entity Public Float 4.9M USD -31%
Common Stock, Value, Issued 6.78K USD +271%
Weighted Average Number of Shares Outstanding, Basic 503K shares +249%
Weighted Average Number of Shares Outstanding, Diluted 503K shares +249%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.84M USD -60.8%
General and Administrative Expense 6.45M USD -27.1%
Operating Income (Loss) -9.63M USD +41.4%
Nonoperating Income (Expense) 66.2K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.57M USD +44.6%
Income Tax Expense (Benefit) 1.73K USD
Net Income (Loss) Attributable to Parent -9.57M USD +44.6%
Earnings Per Share, Basic -19 USD/shares +84.3%
Earnings Per Share, Diluted -19 USD/shares +84.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 2.73M USD -23.6%
Property, Plant and Equipment, Net 306K USD -39.7%
Operating Lease, Right-of-Use Asset 9.61K USD -92.1%
Intangible Assets, Net (Excluding Goodwill) 169K USD
Goodwill 253K USD -82.8%
Assets 3.08M USD -28.3%
Accounts Payable, Current 522K USD -57.2%
Accrued Liabilities, Current 732K USD -31.9%
Liabilities, Current 1.49M USD -36.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -595K USD -4.35%
Retained Earnings (Accumulated Deficit) -106M USD -9.92%
Stockholders' Equity Attributable to Parent 1.59M USD -18.6%
Liabilities and Equity 3.08M USD -28.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.6M USD +49.4%
Net Cash Provided by (Used in) Financing Activities 6.66M USD
Net Cash Provided by (Used in) Investing Activities -5.17K USD +99%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 678K shares +271%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.07M USD
Deferred Tax Assets, Valuation Allowance 13.7M USD +6.37%
Depreciation 169K USD -3.7%
Payments to Acquire Property, Plant, and Equipment 5.17K USD -99%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.6M USD +45.1%
Operating Lease, Liability, Current 9.61K USD -91.3%
Deferred Tax Assets, Operating Loss Carryforwards 12M USD +10.3%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 108M USD +7.35%
Amortization of Intangible Assets 169K USD 0%
Share-based Payment Arrangement, Expense 1.48M USD -26%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%